Histone Deacetylase Inhibition Has Targeted Clinical Benefit in ARID1A-Mutated Advanced Urothelial Carcinoma
组蛋白去乙酰化酶抑制剂已在 ARID1A 突变型晚期尿路上皮癌中显示出靶向临床获益
期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-17-0957
Sumati Gupta ,Daniel J Albertson ,Timothy J Parnell ,Andrew Butterfield ,Alexis Weston ,Lisa M Pappas ,Brian Dalley ,John M O'Shea ,William T Lowrance ,Bradley R Cairns ,Joshua D Schiffman ,Sunil Sharma